View Pages
Markets roundup: Merck boosts sales and guidance on Keytruda strength; Microsoft beats, Alphabet slips after earnings; Caterpillar outperforms on power demand; Marvell reportedly in advanced talks to acquire Lumentum.
Editorial companion
The clip highlights a familiar market pattern: individual corporate news moving whole sectors. Merck raised its full-year profit outlook after Keytruda sales outpaced expectations, a clear earnings beat that investors rewarded. Microsoft posted stronger-than-expected results and lifted sentiment, while Alphabet lagged after its report and Caterpillar moved on continued demand for power-generation equipment tied to AI infrastructure. The episode bundles health-care, industrials, and big tech beats and misses into a tidy snapshot of what’s driving today’s biggest winners and losers.
View Pages
View Pages
View Pages
View Pages